New Patient-Centered Options for Cancer Treat...

In this episode of “Intention to Treat,” host Rachel Gotbaum explores the story of a teenager who’s now in remission from previously relapsed lymphoblastic leukemia and talks with the investigator who developed the “off-the-shelf” CAR T cells that made her treatment possible. A f ...  Show more

This episode of “Intention to Treat,” explores the crisis in primary care in the United States, as increasing numbers or primary care physicians leave the field — driven out by corporatization, growing time pressure, and the inability to form the relationships that enable good ca ...  Show more

Although psychadelic drugs are largely recreational these days, scientists are looking into potential therapeutic uses -- especially in patients for whom nothing else works. Learn how psilocybin may fight depression in this episode of BrainStuff.

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more

Although psychedelic drugs are largely recreational these days, scientists are looking into potential therapeutic uses -- especially in patients for whom nothing else works. Learn how psilocybin may fight depression in this classic episode of BrainStuff. Learn more about your ad- ...  Show more

In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics. We explore the science and therapeutic po ...  Show more